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Introduction
Over the past decade, RNA interference (RNAi) has become recognized as a benchmark laboratory and potential clinical tool to control gene expression, as well as a highly conserved eukaryotic immune response to viral pathogens or transposons. [1] [2] [3] [4] During viral infection, plant and invertebrate cells are known to activate RNAi, where viral RNA is specifically recognized by the cytoplasmic RNase-III-type endonuclease Dicer and degraded by an RNA-induced silencing complex (RISC). Dicer cleaves exposed stretches of double-stranded RNA into small interfering RNAs (siRNAs) 21-24 nucleotides in length (depending on species). Dicer then delivers the double-stranded siRNA, via the RISC-loading complex, 5 to RISC, 6, 7 where the passenger strand of the duplex is cleaved and released, while the guide strand is retained to guide specific cleavage of complementary viral RNA genomes or transcripts. 8, 9 Dicer is thus thought to play a critical dual role in RNAi by both generating virus-specific siRNA duplexes and assembling them with the necessary protein components into active RISC. 10 In mammalian cells, including human cells, artificial siRNAs have been shown to confer antiviral immunity, 11 but only very recently has evidence emerged to suggest that small RNAs, including siRNAs, are also directly generated from infecting viruses. 12 To subvert the host RNAi response, many viruses have evolved small proteins that act as RNA silencing suppressors (RSS). 13, 14 One of the best characterized RSS is exemplified in the plant pathogen Carnation Italian Ringspot Virus (CIRV), which encodes a 19-kDa protein termed p19, an important pathogenicity factor that is highly conserved among all tombusviruses.
14 Crystal structures 15, 16 and recent molecular dynamics simulations 17 show that homodimers of p19 bind a single siRNA duplex in a positively charged surface cleft (Fig. 1a) . Pairs of tryptophan residues stack on both terminal base pairs to establish a sequenceindependent caliper-like size selection for siRNA duplexes with 19 bp and 2-nucleotide-long 3′-overhangs. Sequestration and binding of Dicer-generated siRNAs by p19 have been observed to correlate with reduced viral RNA degradation, systemic symptom spread, and sustainability of viral phenotype after infection. [18] [19] [20] [21] Previous electrophoretic mobility shift assays (EMSAs) have suggested that the affinity of dimeric p19 for siRNA is high, with an apparent equilibrium dissociation constant of K p = 0.17 ± 0.02 nM. 15 Such tight binding is consistent with a widely accepted sequestration model wherein the p19 dimer near-quantitatively binds siRNA duplexes to suppress RNAi. 14, 18 Binding of doublestranded RNA is considered to be the most common RSS mechanism, 22 ,23 yet measurements of siRNA binding and dissociation kinetics to better understand sequestration have not been reported to date for any RSS protein.
Here we develop solution-based fluorescence quenching assays that observe siRNA:p19 (SP) binding to be readily reversible, with not only a rapid 24, 25 Our results are consistent, within error, with the high apparent affinity measured in EMSAs, yet expand on the sequestration model. If binding were completely irreversible, it would require the virus to generate sufficient quantities of p19 dimer to quantitatively bind all small RNAs produced enzymatically by either Dicer cleavage or amplification effected in a plant cell through RNA-dependent RNA polymerase. 2 By contrast, facile reversibility of SP complex formation opens the possibility that multiple turnover may potentiate p19's efficacy as RSS. In particular, if p19 were to disrupt siRNA:Dicer (SD) interaction via multiple turnover, it would potently interfere with the role of Dicer as obligatory RISC assembly factor.
Consistent with such a mechanism of p19 action, we observe the efficient competition of p19 for siRNA binding with active recombinant human Dicer in the absence of other known RISC components, as well as the prominent disruption of RISC assembly complexes observed in human HeLa cell extract containing the three core RISC-loading complex components Dicer, TRBP, and Ago2. 5 Mathematical modeling demonstrates that the Dicer competition data are only accurately reproduced by assuming the formation of a transient ternary complex, siRNA:Dicer:p19 (SDP). Taken together, there emerges a multiple-turnover "catchand-release" mechanism, wherein p19 repeatedly promotes the dissociation of SD complexes to efficiently suppress Dicer-mediated RISC assembly.
Results

Fluorescence assays to observe SP complex formation
We site-specifically labeled the antisense (guide) strand of an established luciferase-targeting siRNA duplex 26, 27 with either fluorescein or tetramethylrhodamine as fluorescence quenching probe in positions not expected to interfere with p19 binding (Fig. 1a) . We found that only the tetramethylrhodamine label was efficiently quenched upon p19 addition (Fig. 1b) . Addition of buffer or other proteins such as recombinant Dicer caused no such quenching (Fig. S2 ). To observe a robust quenching signal upon p19 addition, we proceeded to label with both fluorophores together, allowing us to monitor a normalized tetramethylrhodamine/fluorescein (T/F) fluorescence ratio that is insensitive to dilution effects and other perturbations of an otherwise relative fluorescence signal. Next, we tested by EMSA the p19 binding of this doubly labeled siRNA against that of the unlabeled siRNA and detected no interference from the fluorophores (K p = 0.17 ± 0.03 nM in both cases), consistent with earlier EMSA studies 15 ( Fig. 1c) . Time-resolved fluorescence resonance energy transfer (FRET) between the two fluorophores revealed only a small increase in fluorophore distance distribution upon p19 addition (with the mean distance increasing from 43.4 Å to 44.5 Å; Fig. 1d ), indicating that formation of the SP complex leads to only a minor deformation of the siRNA duplex, as expected from X-ray crystallography. 15 We conclude that the doubly labeled siRNA duplex is a suitable reporter for the formation of the SP interaction in solution.
p19 binds siRNA rapidly and reversibly Addition of increasing excess concentrations of p19 to the doubly labeled siRNA led to an increase in the pseudo-first-order rate constant of tetramethylrhodamine quenching, as monitored by the T/F ratio, yielding a bimolecular binding rate constant of k on = (1.69 ± 0.07) × 10 8 M − 1 s − 1 ( Fig. 2a and b) . Next, dissociation of the preformed SP complex was monitored upon the addition of a large excess of unlabeled siRNA (chase), yielding a dissociation rate constant of k off =0.062 ±0.002 s − 1 ( Fig. 2c; Fig. S2 ). Together with rapid k on , a solution-based dissociation equilibrium constant of k off /k on = K p,sol = 0.37 ± 0.08 nM is obtained within 2-fold of the EMSApredicted value (0.17 nM), attesting to a high-affinity yet also notably reversible SP binding mode. p19 efficiently competes with recombinant human Dicer for siRNA binding
The critical dual role of Dicer in RNAi as the enzyme that produces siRNAs and as an RISC assembly factor 10 suggests the SD interaction as a particularly vulnerable step during RNA silencing. Previous studies in embryo extracts of the fruit fly Drosophila have shown that p19 suppresses RNA silencing by competing with the Dcr2-R2D2 complex. 18, 22 To determine whether p19 also competes with human Dicer for siRNA, we employed EMSA using radiolabeled siRNA duplexes and an active recombinant human Dicer preparation devoid of other known RISC proteins (Fig. S1 ) [available as a relatively crude purification of heterologously overexpressed Dicer (Genlantis); see Materials and Methods]. We measured the apparent equilibrium dissociation constant of the human SD complex as K d = 3.7 ± 0.4 nM ( Fig. 3a; Fig. S3a ). The presence of a low concentration of p19 (0.17 nM), equivalent to the K p of the SP complex, weakened this interaction by N 25-fold to~100 nM ( Fig. 3a; Fig. S3b ). The presence of a saturating concentration of p19 (2.5 nM) weakened the interaction still further by N 270-fold to an estimated lower limit of~1.0 μM ( Fig. 3a; Fig. S3c ). These findings led us to hypothesize that p19 can function to inhibit RNAi in humans by interrupting the SD complex before Dicer can hand off siRNA to RISC. Reciprocal competition experiments showed that the presence of even saturating concentrations (140 nM) of Dicer lowered the apparent affinity of p19 for siRNA only marginally (~4-fold from 0.17± 0.03 nM to 0.81± 0.06 nM; Fig. 3b ; Fig. S3d and e) , further supporting the hypothesis that strong competition with the SD complex is an important mode of action for p19 inhibition of RNAi in human cells.
Human siRNA-containing complexes formed in cytosolic cell extract are vulnerable to p19 challenge Previous studies with Drosophila extracts have shown that p19 inhibits RISC assembly while disrupting preassembled RISC to a lesser extent. 22 Our result that p19 disrupts the complex of recombinant human Dicer with siRNA suggests that p19 may also be effective in suppressing RISC assembly in mammals. To test this hypothesis and to probe p19's effect on the formation of human RISC-related complexes, we used a modified in vitro RISC assembly assay.
28,29 Specifically, we incubated radiolabeled siRNA duplex with 15% (vol/vol) cytosolic HeLa cell extract, which we showed to contain the three core RISC-loading complex components Dicer, TRBP, and Ago2 (Figs. S1 and S5), and analyzed the products by EMSA and autoradiography ( Fig. 4a and b) . We observed three distinct siRNA-containing complexes that correspond to those previously observed, including a slowly migrating complex D that is thought to contain Dicer, as well as two faster-migrating bands termed C1 and C2 18, 30 (Fig. 4b) . The normalized fraction of complex C2 decreases over a 2-h period, whereas the complex C1 and D fractions increase (with estimated rate constants of 2 × 10 − 3 s − 1 , 0.8×10 − 3 s − 1 , and 0.4 × 10 − 3 s − 1 , respectively; Fig. 4a ). To test for the presence of Dicer, we performed supershift assays with anti-Dicer polyclonal antibody and found that only complex D specifically supershifts with this antibody (Fig. 4c) . Similarly, Dicer is detected by Western blot analysis in complex D only (Fig. S5) . Notably, adding increasing p19 concentrations to the cell extract prior to siRNA addition increasingly impairs the formation of all three siRNA-containing complexes, concomitant with an accumulation of the competing SP complex ( Fig. 4d and e). When p19 is added to the RISC assembly assay after 2 h of preincubation with siRNA, the formation of particularly the Dicer-containing complex D is inhibited to a lesser extent ( Fig. 4f and g ). Similar results were obtained at higher HeLa cell extract concentrations and temperatures (Fig. S4) .
Modeling supports the formation of a transient ternary SDP complex
The mechanism of competition between p19 and human Dicer can be determined from mathematically modeling the two possible modes of competition for a two-protein/single-substrate system. First, competition may occur through dissociative binding mode, where the higher-affinity protein shifts the relative equilibrium of the system by binding all of the available substrate as it dissociates from the competitor, thus establishing a new equilibrium position (Fig. 3c ). In the case of p19 and Dicer, siRNAs are preassociated with Dicer at the onset due to their cleavage from longer RNAs, making such dissociative binding by p19 relatively fast only if spontaneous dissociation from Dicer is rapid. Second, competition may occur through formation of a ternary complex intermediate involving siRNA, Dicer, and p19 ( Fig. 3c ). Using the previously determined gel-based apparent dissociation equilibrium constants for p19 (K p = 0.17 ± 0.02 nM) and Dicer (K d = 3.7 ± 0.4 nM), we can discriminate between these two possible modes of competition by calculating the resulting expected SD and SP complex fractions and by comparing them to experiments for a given set of equilibrium conditions. 31 Assumption of the dissociative binding mechanism shows a poor correlation with experiments, as evident from the fact that changes upon Dicer addition are consistently overestimated (Fig. 3a) while changes upon p19 addition are consistently underestimated (Fig. 3b ). This poor correlation suggests that ternary complex formation is needed to explain the observed efficient disruption of the SD complex in the presence of p19. The inclusion of ternary complex formation in the mechanism creates a thermodynamic cycle that requires a K d /K sp ratio equal to the K p /K sd ratio. 32 Rearranging and using the values of K d and K p , we find that K sp /K sd = K d / K p = 21.6 and, therefore, K sp = 21.6K sd . This result suggests that dissociation of the ternary complex into the binary SP complex is N 20-fold more likely than dissociation into the SD complex, indicating that siRNAs can indeed be effectively shuttled toward the p19-bound state by assuming the transient formation of a ternary SDP complex. The resulting model correlates well with experiments and explains both the weak effect that Dicer addition has on the SP complex and the large effect that p19 addition has on the SD complex ( Fig. 3a and  b) . A similar result is observed when p19 is placed in the context of the RNAi pathway, as follows.
Modeling illustrates the benefits of reversible siRNA binding by p19
To further interpret and unify our results, we expanded a previously published, simplified steady-state kinetic model that encapsulates key features of the RNAi pathway, including RNA cleavage by Dicer, siRNA incorporation into RISC, and the resulting RISC-mediated RNA degradation. 33 We included the experimentally observed competition of p19 with the SD interaction and p19's reversible interaction with siRNA. From this model, there emerges the possibility of a multiple-turnover "catch-and-release" mechanism wherein p19 is effectively recycled after successfully competing with Dicer and dissociating again from the siRNA (Fig. 5a ). We next sought to establish what impact, if any, such a mechanism has on the ability of p19 to suppress RNAi (for details of the model and its analysis, see Supplementary Information).
Our model suggests that the intracellular steadystate load of viral proteins (and thus viral viability) is specified by three global parameters (Fig. 5a ): the efficiencies of Dicer (A), RNAi in the specific host cell type (y), and p19 (v). These three global parameters are each composed of detailed mechanistic parameters (Table 1 and Supplementary Information). In the case of the irreversible binding of p19 to an siRNA (single turnover), the relative enhancement of viral protein load in the presence of p19 over the absence of p19, ϕ Irr , is then described by:
leading to a negligible dependence on the p19 suppression efficiency v (Fig. 5b) when using a realistic parameter space (Table 1 and Materials and Methods).
In the case of a reversibly formed SP complex, as observed in our experimental work, two additional model parameters come into play (Fig. 5a ): the fraction of siRNAs that successfully reenters the RNAi pathway after release from p19 (n) and the fraction of total p19 that is bound to siRNA (a). Values of n close to zero lead to a recycling of p19 protein without a reincorporation of the released siRNA into RISC, whereas values of n close to unity effectively reduce the free concentration of p19 without changing the fate of the bound siRNA as an eventual guide for RISC. Previous studies have shown that Dicer substrates at subnanomolar concentrations are up to 100-fold more effective in gene knockdown than mature siRNAs, 6,37 suggesting a low probability of n = 0.01 for reincorporation of free siRNA into the RNAi pathway especially at the low siRNA concentrations expected during the early stages of viral infection. Previous experimental studies in Drosophila embryo lysate have shown that p19 is effective in preventing low nanomolar concentrations of siRNAs from incorporating into RISC but is less effective in disrupting mature RISC, 18, 22 a feature that is also evident in our data Fig. 4e and g ), suggesting that, indeed, early stages of viral infection (where n is small) may be most effective for RNAi suppression by p19. The relative enhancement of viral protein load in the presence of p19 over the absence of p19 in our reversible binding model, ϕ Rev , is then described by:
where k off is the dissociation constant of the SP complex, and k cat D is the cleavage rate constant of Dicer. This model predicts a hyperbolic dependence of ϕ Rev on the p19 efficiency v, with little dependence on a (Fig. 5b) , which can be estimated from our experimental data in Fig. 3a and b to range between 0.1 and 200. Reversible siRNA binding by p19 is thus found to enhance viral protein production by up tõ 2.2-fold over that observed for the irreversible binding model (Fig. 5b) . Notably, even a value of n = 0.1 does not diminish this effect much due to a close-to-linear decrease in ϕ Rev toward unity, with an increase in n toward unity (data not shown).
Discussion
The small positive-sense single-stranded RNA genome of tombusviruses encodes p19, an RSS thought to be critical for symptom spread and for the cytotoxicity of this class of plant pathogens 20, 21, 38, 39 through its ability to bind and thus sequester Dicer-generated siRNAs. 14, 18 The proposed use of p19 in therapeutic and research applications, including mammalian gene therapy, 40 vaccine production, 41, 42 and as human retroviral protein homolog, 43 motivates the study of p19 outside its natural host environment, across kingdom boundaries. We here have investigated the binding of a generic siRNA by CIRV p19 through fluorescence quenching assays in combination with radioactive EMSAs. The noticeable dissociation of an siRNA from p19 (k off = 0.062 ± 0.002 s − 1 ) is counterbalanced by fast association to yield a solution-based dissociation equilibrium constant (K d = 0.37 ± 0.08 nM; Fig. 2 ) within 2.2-fold of the high affinity previously estimated from gel-based, inherently non-equilibrium EMSAs. 15 The dissociation of siRNA from p19 is nearly 3 orders of magnitude faster than that observed for many high-affinity nucleic acid-protein complexes, with dissociation rate constants on the order of 10 − 4 s − 1 . 24, 25, 44, 45 Strikingly, the rate and equilibrium constants for the SP complex resemble those of the human immunodeficiency virus-1 protein Rev for interaction with the Rev response element RNA (k on = 5.3 × 10 8 M − 1 s − 1 ; k off = 0.14 s − 1 ), perhaps due to the similarly (primarily) non-sequence-specific binding of a small protein to a (partially) base-paired RNA duplex. 46 The presence of even low concentrations of p19 dramatically weakens the interaction of recombinant human Dicer with its siRNA product (25-fold to N 270-fold, depending on the p19 concentration; Fig. 3a ) in the absence of other detectable RISC components. Conversely, the presence of saturating concentrations of Dicer only slightly lowers (~4-fold) the affinity of p19 for siRNA (Fig. 3b) , supporting the hypothesis that strong competition with the SD complex is an important mode of p19 action in vivo. Accordingly, assembly assays show that p19 also strongly disrupts the RISC-related human siRNA-protein complexes observed in HeLa cell extract that we show to contain all core RISCloading complex components (Dicer, Ago2, and TRBP; 5 Fig. S1d and e), suggesting that p19 is able to disrupt the SD complex even in the context of the full complement of RISC components (Fig. 4) . Our experimental results inform the mathematical modeling of the competition between Dicer and p19 for siRNA, as well as of the steady-state interactions between siRNA, Dicer, p19, RISC, and viral (m) RNA. We determine that the minimal model necessary to achieve the experimentally observed level of competition of p19 with Dicer for siRNA Grouped parameters y RNAi efficacy parameter specific for HEK293 cells Marshall 33 
A
Dicer efficacy parameter k cat D /r dp 2.33 × 10 7 β RNAi settling time r ds /r dp requires the postulation of a transient ternary complex that favors dissociation into the SP complex and free Dicer (Fig. 3) . In addition, an expanded steady-state kinetic model predicts a significant enhancement in viral protein load when the SP interaction is assumed to be reversible, as observed experimentally. Our results thus invoke a multipleturnover "catch-and-release" mechanism wherein p19, unlike the released siRNA, 6,37 is effectively recycled after successfully competing with Dicer (Fig. 5) . Notably, if the dissociation rate constant of the SP complex were lower and thus closer to that of a slow-release protein, p19 would be more efficient in competing with Dicer for siRNA but also less efficient in releasing the siRNA to achieve multiple turnover. It is tempting to speculate that evolution in this way has yielded a p19 with siRNA binding properties optimized for RNAi suppression.
As any mathematical model, our model relies on some assumptions, including an experimentally derived estimate for a low probability n of 1% for the reincorporation of siRNA released from p19 into the RNAi pathway. 6, 37 The dependence of the predicted RNAi suppression has a relatively shallow dependence on n and, for any n b 1, predicts an enhancement of suppression through the experimentally observed reversibility of the SP interaction. Strikingly, the estimated 2.2-fold enhancement in RNAi suppression through reversible SP complex formation is similar in magnitude to the typical RNAi effect that microRNAs (miRNAs) have on the expression of cellular genes, 9, 47 suggesting that even a modest change in gene expression level as predicted here can have profound biological consequences, in our case on the likelihood of the survival of a virus in its host.
Several implications for the struggle between the virus and the cellular RNAi machinery arise from our work. First, in gene therapeutic applications, p19 will be required to be effective outside of its natural host environment, where a study of the protein's potential interaction partners so far has been lacking. Here, we observe p19 in the context of human cellular components and find evidence for ternary complex formation between p19, an siRNA, and human Dicer. Our experimental data suggest that the observed efficient competition of p19 with the SD complex (Fig. 3) and with the resulting Dicercontaining RISC assembly complexes (Fig. 4) targets a particularly critical step on the path to an activated RISC. Recent three-dimensional reconstructions from negatively stained electron microscopy images of human Dicer complexes depict it as a fist-like shape with a central flat surface that is thought to bind the siRNA. 4, 48, 49 This architecture, along with the known binding mode of p19, raises the possibility that p19 could bind the opposite face of the siRNA in a ternary complex with Dicer. Notably, crystal structures of several other viral suppressors also appear to bind only one face of the siRNA, leaving the opposite face open to potentially accommodate proteins such as Dicer. 50 While we did not observe the formation of a supershifted band as indicative of such a ternary complex in our EMSAs with siRNA, p19, and human Dicer (Fig. 4d-g ), the complex may simply be too short-lived or our EMSA may simply be too low in resolution for the complex to be detected.
Second, the previously proposed simple sequestration model would require stoichiometric p19 concentrations relative to all siRNA duplexes (native to CIRV or not) generated by Dicer, as well as all other small duplex RNAs bound by p19, including defective interfering RNAs, 20 siRNA amplification products generated in plant and other cells by RNAdependent RNA polymerase activity, 2,51 and perhaps miRNA duplexes. 19, 52, 53 We independently confirmed the ability of p19 to bind a human miRNA using the conserved, ubiquitous, and wellstudied let-7a miRNA, which has been implicated as a tumor suppressant. 54 Remarkably, we observed that p19 binds the partially mismatched, doublestranded 22-nucleotide let-7a miRNA and our 21-nucleotide siRNA with equal affinities of 0.16 ± 0.02 nM and 0.17 ± 0.03 nM, respectively (Fig. S8) . Similar to our observations, a recent study used an affinity-capture approach to show that p19 from CIRV retains a high affinity for let-7 miRNA, as well as a fluorophore-labeled siRNA. 53 These observations further underscore that p19 may face a large background of competitor RNAs while targeting its siRNA substrate, although the specific base-pairing patterns of some plant miRNAs may disfavor their binding to p19. 55 Our finding that formation of the high-affinity SP complex is readily reversible (Fig. 2 ) while still interfering with siRNA binding by Dicer and RISC-related assembly complexes in vitro (Figs. 3 and 4) raises the possibility that substoichiometric p19 concentrations may suffice in vivo to prevent siRNAs (by multiple turnover) from assembling into RISC. In this fashion, the virus could keep pace with the amplified host response during systemic RNAi self-defense of the plant host against CIRV. 56 Third, while our results have an immediate impact on our understanding of the physicochemical properties and biological function of p19, a more practical consideration also arises from our work. The future of RNAi-based strategies may well be dependent on the ability to control and predict the relative intracellular expression levels of RISC components and potential therapeutics. 40, 57 For example, short hairpin RNAs, while shown in vivo to efficiently induce gene silencing, have been found in long-term investigations to cause dose-dependent liver injury and ultimately death in adult mice when sustained at high levels, 57 and to cause dysregulation of miRNAs and increased tumorigenesis when marginally dosed. 58 Coexpression with p19 could help ameliorate such toxic effects of short hairpin RNAs. In addition, CIRV p19 and other RSS have been shown to aid in the transfection and difficult overexpression of alpha viruses, adenoviruses, and lentiviruses used in gene therapy and plant-based vaccines, through their ability to suppress the intracellular RNAi immune response. 40 For such immunosuppression to be effective, dosing of the RSS is important, analogous to the use of immunosuppressants after organ transplant surgery. In fact, our observation that at least some miRNAs tightly bind to p19 cautions that adverse developmental effects due to a sequestration of essential cellular RNAs have to be carefully avoided. Understanding and modeling relevant biophysical properties of RNAi processes in the presence of RSS, as advanced here, are thus anticipated to become critical for a broader and safer use of RNAi therapeutics in human disease control.
Materials and Methods
Sources of p19, Dicer, HeLa cell extract, and RNA Purified p19 protein was prepared as previously described, 15 and its dimer concentration was measured by Bradford assay. Recombinant human Dicer was prepared by Genlantis using the Baculovirus system with a commercially available protocol from Invitrogen. The His-tagged Dicer was purified on a Ni 2+ column, and the His tag was removed by Tev protease cleavage, which should remove any contaminating factors that do not remain bound to the recombinant Dicer. S100 cytosolic HeLa cell extract was obtained from Jena Biosciences, and the integrity of Dicer in both samples was tested by Western blot analysis (Fig. S1a) . Additionally, we demonstrated the biological activity of the recombinant Dicer through cleavage assays using long double-stranded RNA substrates (Fig. S1b ). An estimate of Dicer concentration in the partially purified preparation was derived from Bradford assays to measure the total protein concentration in combination with the 5% purity quoted by Genlantis and verified by Coomassie staining of a denaturing SDS-PAGE gel (Fig. S1c) . This estimate is conservative, as higher relative purities would only imply that even higher concentrations of Dicer are needed to efficiently compete with p19 for siRNA binding. All RNAs were synthesized by the HHMI Biopolymer/Keck Foundation Biotechnology Resource Laboratory at the Yale University School of Medicine, then deprotected and purified as previously described. 27, 59 siRNA sequences were derived from the firefly luciferase gene, 26 as follows: sense strand 5′-P-CGU ACG CGG AAU ACU UCG AAA-3′ and antisense strand 5′-P-UCG AAG (fluorescein-dT)AU UCC GCG (amino C6-dT)AC GUG-3′, where P denotes a 5′-phosphate, and fluorescein-dT and amino C6-dT denote the phosphoramidites of the same name from Glen Research; the antisense strand was also synthesized with only one or no modification wherein U replaced the modified dT. Where needed, tetramethylrhodamine was coupled to the amino C6 linker, and the RNA was purified as described previously. 59 miRNA sequences were derived from the human wild-type let-7a miRNA, as follows: let-7a antisense strand 5′-P-UGA GGU AGU AGG UUG UAU AGU U-3′ and let-7a sense strand 5′-P-CUA UAC AAU CUA CUG UCU UUC C-3′.
Steady-state fluorescence spectroscopy
Standard fluorescence measurements were performed on an Aminco Bowman spectrofluorometer (Thermo Scientific) at 37°C. siRNA duplexes were formed by mixing an excess of 100 nM unlabeled sense strand with 50 nM labeled sense strand in near-physiologic standard buffer [50 mM Tris-acetate (pH 7.4), 80 mM KCl, 20 mM NaCl, 1 mM MgCl 2 , 1 mM DTT, and 0.02% (vol/vol) Tween 20], heat annealing for 2 min at 70°C, and cooling to room temperature over 5 min. T/F doubly labeled siRNAs were excited at 490 nm (4 nm slit width), and emission was alternately detected at 520 nm (for fluorescein) and 585 nm (8 nm slit width for tetramethylrhodamine) to calculate the T/F ratio; fluorescein or tetramethylrhodamine singly labeled siRNAs were excited/detected at 490 nm/520 nm or 565 nm/585 nm, respectively. In a typical experiment, p19 was added to 50 nM labeled siRNA and mixed manually to a final concentration of 500 nM, unless otherwise indicated. For a chase experiment, unmodified siRNA duplex (formed by annealing the unlabeled composite sense and antisense RNA strands in a 2:1 ratio in standard buffer) was added to a final concentration of 3 μM. Saturation by the chase was ensured by triplicate trials using 500 nM, 750 nM, 1.5 μM, and 3 μM (Fig. S2) .
To observe fast SP complex formation, we prepared siRNA samples as described above in standard buffer to a final concentration of 40 nM. In standard buffer, p19 was added to varying (at least 8-fold) final excess concentrations (0.32-1.76 μM) at 37°C in a KinTek PMA23B stopped-flow spectrofluorometer while exciting at 520 nm and detecting emission at 585 nm. All time courses were fitted with single-exponential increase or decrease functions in Origin (OriginLab) as described previously. 60 
Electrophoretic mobility shift assays
For radioactive EMSAs, the nonphosphorylated antisense strand was first 5′-32 P-labeled with T4 polynucleotide kinase and [γ-32 P]ATP at an RNA concentration of 800 nM. Polynucleotide kinase was inactivated by heating to 90°C for 10 min, then the 5′ phosphorylated complementary strand was added in 2-fold molar excess, and the reaction was slowly cooled to room temperature to anneal the two strands. The siRNA duplex was further purified by nondenaturing 20% (wt/ vol) PAGE. The duplex siRNA was cut out, eluted overnight into 1 mM ethylenediaminetetraacetic acid (EDTA) at 4°C, ethanol precipitated, and dissolved in RNase-free water. Scintillation counting was performed on a Beckman LS6500 Multipurpose Scintillation Counter. EMSAs were performed 15 on 10-cm nondenaturing 12% (wt/vol) polyacrylamide gels in 0.5× TBE (44.5 mM Tris-borate and 1 mM EDTA) and run at 500 V and 4°C for 2 h, as described previously. Dicer and p19 at varying final concentrations were added to radiolabeled siRNA duplex (50,000 cpm, b400 pM 5′-32 P-labeled duplex) in 10 μl of standard buffer and incubated for 0.5 h. Next, 10 μl of nondenaturing loading buffer (10% glycerol, 0.5× TBE, 0.025% bromophenol blue, and 0.025% xylene cyanol) was added, and each sample was loaded into a well of the EMSA gel. Competition experiments were performed by preincubating b400 pM siRNA duplex (prepared as described above) in standard buffer either with 140 nM Dicer and increasing concentrations of p19, or with 0.17 nM or 2.5 nM p19 and increasing concentrations of Dicer. Gel-chase experiments were performed in standard buffer with 70 nM and 10 nM Dicer or p19, respectively, to b 400 pM 5′-32 Plabeled siRNA and with addition of 750 nM unlabeled siRNA chase for 0 min, 10 min, 30 min, 60 min, and 120 min. Gels were wrapped in plastic wrap and exposed to phosphor screens, which were scanned on a Storm 840 PhosphorImager and quantified using Image Quant software (Molecular Dynamics). The relative fraction f of relevant protein complexes was fitted with the following hyperbolic binding isotherm to extract the saturation point f max and the half-titration point K d,app :
RISC assembly complex formation
To observe RISC assembly complexes, we incubated 15%, 50%, or 75% (vol/vol) cytosolic HeLa cell extract with b400 pM siRNA duplex (prepared as described above) in a final volume of 10 μl of HeLa buffer-8% (vol/ vol) lysis buffer [23.7 mM Hepes (pH 7.5), 79 mM potassium acetate, 1.58 mM magnesium acetate, 5 mM DTT, and 1 mg ml − 1 Perabloc SC (Roche)], supplemented with 20% (vol/vol) 5× RNAi mix (125 mM creatine phosphate, 5 mM ATP, and 25 mM DTT), 2% (wt/vol) creatine kinase, and 20% (vol/vol) RNA guard RNase Inhibitor (GE Bioscience)-for 2 h at 4°C, unless otherwise specified. For competition experiments, p19 was added in increasing concentrations to the HeLa cell extract/siRNA mixture either immediately or after a 2-h preincubation. Time courses were stopped by direct loading onto a running nondenaturing 4% (wt/vol) polyacrylamide gel in 0.5× TBE, then run at~50 mW cm − 2 and 4°C. For comparison with a previous assay, 50% and 75% (vol/vol) HeLa cell extract was incubated with siRNA as described by Pellino et al. for 1 h at 4-37°C and analyzed by EMSA, yielding similar results (Fig. S4) . 28 Fifteen percent (vol/ vol) extract was preferred for most of our work due to the better pH control afforded by this lower concentration and to conserve material. For antibody supershift EMSA, cytosolic HeLa cell extract (24 μg of total protein) was preincubated with 0.8 μg or 1.6 μg of anti-Dicer rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc.) and 0.8 μg or 1.6 μg of unrelated control antibodies-either anti-DsRed rabbit polyclonal antibody (Clontech Laboratories, Inc.) or anti-β actin mouse monoclonal antibody (Sigma-Aldrich, Inc.)-for 2 h at 4°C prior to the RISC assembly assay. The final volume was 60 μl per lane. Nondenaturing 4% (wt/vol) PAGE was used to resolve these complexes, as described above. Time courses and titration curves were fitted as described above.
Time-resolved FRET
Time-resolved donor (fluorescein) fluorescence decays were collected in the presence and in the absence of acceptor (tetramethylrhodamine) using time-correlated single-photon counting, as previously described. 61, 62 As before, the donor decay in the presence of acceptor was modeled as a weighted average of the decays for each donor-acceptor distance in the ensemble of molecules assuming a three-dimensional Gaussian distance distribution with a Förster distance of 54 Å between fluorescein and tetramethylrhodamine. 61, 62 Western blot analyses for Dicer detection For denaturing Western blot analyses, the cytosolic HeLa cell extract, the recombinant Dicer enzyme preparation, and the recombinant TRBP (Abcam) and Ago2 (Abnova) proteins were run on a NuPAGE Novex 4-12% gradient 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol gel in the presence of a molecular weight marker (ECL Plex Rainbow marker). The gel was then electroblotted in Tris-glycine buffer [25 mM Tris, 192 mM glycine, and 20% (vol/vol) methanol] onto a polyvinylidene fluoride membrane (Immobilon-P Membrane; Millipore) over 75 min at 300 mA, using a Bio-Rad Trans-Blot SD semidry transfer cell as per the manufacturer's instructions. After transfer, the membrane was probed with rabbit anti-Dicer antibody (Santa Cruz Biotechnology) and mouse anti-TRBP or mouse antiAgo2 antibody (both Abnova), followed by goat antirabbit-Cy5 and goat anti-mouse-Cy3 antibodies (both Amersham), respectively. The probed blots in Fig. S1a, d , and e were visualized on a Typhoon 9410 Variable Mode Imager (GE Healthcare Life Sciences).
For nondenaturing Westerns blot analyses, RISC assembly complexes were formed as described above, but reactions were scaled up by 6-fold. Gels were soaked in 0.1% (wt/vol) SDS for 15 min and then electroblotted in Tris-glycine transfer buffer (25 mM Tris and 25 mM glycine) onto a polyvinylidene fluoride membrane (Immobilon-P Membrane; Millipore) over 75 min at 300 mA, using a Bio-Rad Trans-Blot SD semidry transfer cell as per the manufacturer's instructions. After transfer, the proteins were fixed to the membrane by incubating in 5-10% (vol/vol) acetic acid, rinsing with deionized water, and air drying. The membrane was probed with a rabbit primary antibody against Dicer (Santa Cruz Biotechnology), followed by a goat anti-rabbit secondary antibody conjugated with horseradish peroxidase (Zymed; Invitrogen). The blot was developed using a peroxide/enhancer solution (ECL-Plus detection; Amersham) and visualized on a Typhoon 9410 Variable Mode Imager (Fig. S5) .
Modeling p19 in the context of RNAi
For the model described schematically in (Fig. 5a) , changes in viral protein expression levels were monitored at steady state in the absence and in the presence of the RSS p19. Changes in free p19 protein over time depend on terms representing the natural rates of production (r x r t / r dm ), degradation (r dp [p19]), extent of siRNA binding (k on [siRNA] [P]), and SP complex dissociation (k off [SP] ).
Production of p19 is governed by its transcription rate (r x ), its messenger RNA (mRNA) degradation rate (r dm ), and its translation rate (r t ), which are assumed to have reached equilibrium on a timescale faster than that of repression. The p19 protein is degraded by the first-order rate constant (r dp ), leading to:
p19 Vs ½ = r x r t r dm − r dp p19
The amount of usable siRNA in the system (i.e., the fraction that is able to associate with RISC) is reduced by the amount of siRNA bound to p19. Production of siRNA is dependent on the catalytic rate constant of Dicer (k cat D ), and siRNA is degraded with a first-order rate constant (r ds ). The parameter n is the fraction of siRNA that reenters the RNAi pathway after p19 dissociation, yielding:
The time evolution of the viral protein of interest that serves as a reporter of RNAi suppression and p19 enhancement is described as:
viralVs ½ = r x r t kcat R KDR RISC ½ siRNA ½ + r dm − r dp viral ½ ð3Þ
where (k cat R ) is the catalytic rate constant for the RISCmediated cleavage of mRNA. The additional term in the denominator of Eq. (3) is a quasi-steady-state assumption used in previous work 33, 63 to describe RISC-mediated degradation of viral mRNA. It assumes that the active concentration of siRNA-loaded RISC approaches its steady-state value with the rate constant k cat R . This buildup of siRNA-loaded RISC contributes to the rate of degradation of the viral mRNA, as described by the concentrations of RISC and siRNA, as well as the dissociation constant K dr . The proteins not silenced by RNAi are represented at steady state by unitless constants: Dicer ½ = r x r t r dp r dm ð4Þ RISC ½ = r x r t r dp r dm ð5Þ
Equations (1)-(3) are rescaled as described by Marshall and solved at steady state to yield: where y and β are the parameters previously described as the efficiency of the RNAi pathway and the RNAi settling time, respectively. 33 The parameters a, v, and A are the fraction of siRNA-bound p19 relative to total p19, the efficiency of p19, and the efficiency of Dicer in a particular cell line, respectively. The level of the viral protein at steady state is dependent mostly on S. For example, in the absence of RNAi (i.e., in the absence of Dicer), S = 0, so that V =1 (i.e., the viral protein level is not suppressed). Substituting Eq. (6) into Eq. (7) yields two solutions for S, where we choose S 2 as the more biologically relevant one: 
In the absence of p19 (i.e., P = 0), based on Eqs. (7) and (8) , V reduces to the fully suppressed protein level:
The enhancement of viral protein production due to either irreversible (ϕ Irr ) or reversible (ϕ Rev ) p19 binding is then found to be (see also Fig. 5b ):
Supplementary materials related to this article can be found online at doi:10.1016/j.jmb.2011.02.038
